Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taodan Granules for Psoriasis Vulgaris
NCT03942198Phase 2Unknown
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jun 2019
- Primary completion
- Dec 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Taodan granules in Psoriasis vulgaris (PV) (2 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Psoriasis Area and Severity Index. Status: unknown.
02
Drugs
Taodan granules
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT03942198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03942198.